Presentation TCT 2018 Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker September 23, 2018
Presentation TCT 2018 Case #4: Clinically Significant TAVR Leaflet Thrombosis Presenter: Samir R. Kapadia, Bernard Prendergast, Eric Eeckhout, Ganesh Manoharan, John C. Messenger, Bernhard Reimers, Paul Sorajja, Eric Vang September 23, 2018
Presentation TCT 2018 Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas September 22, 2018
Presentation TCT 2018 New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno September 22, 2018
Presentation TCT 2018 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard September 22, 2018
Presentation TCT 2018 To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum September 22, 2018
Presentation TCT 2018 To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla September 22, 2018
Presentation TCT 2018 How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke September 22, 2018
Presentation TCT 2018 Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb September 22, 2018
Presentation TCT 2018 Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah September 21, 2018
News Conference News PCR London Valves 2018 Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications Shelley Wood September 10, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News ‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions Yael L. Maxwell August 17, 2018
News Daily News Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness Caitlin E. Cox July 16, 2018
Presentation The Structural Heart Disease Summit 2018 Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends Presenter: Michael J. Mack, Raj Makkar June 22, 2018
Presentation The Structural Heart Disease Summit 2018 New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS June 22, 2018
Presentation The Structural Heart Disease Summit 2018 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard June 22, 2018
Presentation The Structural Heart Disease Summit 2018 Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD June 21, 2018
News Daily News Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk Michael O'Riordan June 20, 2018
News Daily News Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves L.A. McKeown June 12, 2018